Investigational Drug Information for Phenylacetic acid
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Phenylacetic acid?
Phenylacetic acid is an investigational drug.
There have been 8 clinical trials for Phenylacetic acid.
The most recent clinical trial was a Phase 1 trial, which was initiated on February 20th 2018.
The most common disease conditions in clinical trials are Drug-Related Side Effects and Adverse Reactions, Liver Cirrhosis, and Fibrosis. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Pharma Ireland, Ltd., Dublin Ireland, and Yiling Pharmaceutical Inc.
There are seven hundred and seventy-nine US patents protecting this investigational drug and forty-two international patents.
Summary for Phenylacetic acid
| US Patents | 779 |
| International Patents | 42,919 |
| US Patent Applications | 3,830 |
| WIPO Patent Applications | 1,977 |
| Japanese Patent Applications | 9 |
| Clinical Trial Progress | Phase 1 (2018-02-20) |
| Vendors | 59 |
Recent Clinical Trials for Phenylacetic acid
| Title | Sponsor | Phase |
|---|---|---|
| A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Phase 3 |
| Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome) | Weizmann Institute of Science | Phase 2/Phase 3 |
| Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome) | Kaplan Medical Center | Phase 2/Phase 3 |
Clinical Trial Summary for Phenylacetic acid
Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid
US Patents for Phenylacetic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phenylacetic acid | See Plans and Pricing | Compositions containing polymeric, ionic compounds comprising imidazolium groups | BASF SE (Ludwigshafen, DE) | See Plans and Pricing |
| Phenylacetic acid | See Plans and Pricing | Pyrrolidine amide compounds as histone demethylase inhibitors | GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) | See Plans and Pricing |
| Phenylacetic acid | See Plans and Pricing | Anti-viral compounds | AbbVie Inc. (North Chicago, IL) | See Plans and Pricing |
| Phenylacetic acid | See Plans and Pricing | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof | Cody Laboratories, Inc. (Cody, WY) | See Plans and Pricing |
| Phenylacetic acid | See Plans and Pricing | System and method for diagnosis and treatment | See Plans and Pricing | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phenylacetic acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phenylacetic acid | China | CN107001386 | 2034-10-11 | See Plans and Pricing |
| Phenylacetic acid | European Patent Office | EP3204392 | 2034-10-11 | See Plans and Pricing |
| Phenylacetic acid | Japan | JP2017531655 | 2034-10-11 | See Plans and Pricing |
| Phenylacetic acid | World Intellectual Property Organization (WIPO) | WO2016055553 | 2034-10-11 | See Plans and Pricing |
| Phenylacetic acid | China | CN105051106 | 2033-03-12 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
